ArticleQuantitative imaging in medicine and surgery2026
Optimization of high-concentration (400 mgI/mL) contrast media volume for abdominal computed tomography: a comparison between fixed-dose and total body weight-based protocols.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Contrast-enhanced computed tomography (CT) is routinely employed for diagnosing abdominal diseases. Individualized contrast media (CM) dosing protocols are vital for patient safety and image quality. This study aimed to compare the vascular and parenchymal enhancement effects and overall image quality between fixed-dose and total body weight (TBW)-based high-concentration (400 mgI/mL) CM dosing protocols in abdominal multiphasic contrast-enhanced CT. Methods: Patients scheduled for abdominal multiphasic CT were retrospectively enrolled and placed into the TBW-based dosing group or the fixed-dose group (80 mL CM at 120 kVp). The TBW-based dosing group was further divided into five subgroups: 400 mgI/TBW (kg) at 100 kVp, 400 mgI/TBW (kg) at 120 kVp, 450 mgI/TBW (kg) at 100 kVp, 450 mgI/TBW (kg) at 120 kVp, and 500 mgI/TBW (kg) at 120 kVp. The CT attenuation values of blood vessels and organs were measured, and the contrast enhancement index (CEI), signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) were calculated. Results: There were no significant differences observed in age, sex, TBW, or body mass index between the fixed-dose group and TBW-based subgroups. The TBW-based dosing groups received a significantly lower volume of CM compared with the fixed-dose group (P<0.001). Moreover, the fixed-dose group and TBW-based subgroups were significantly different in terms of the CEI of the aorta, portal vein, and hepatic vein, as well as the SNR and CNR of the aorta, portal vein, kidney, pancreas, liver, and hepatic vein (all P<0.001) but not the SNR of the hepatic vein in the portal venous phase (P=0.050). No significant differences in subjective image quality were found between the 450 mgI/TBW (kg) at 100 kVp, 500 mgI/TBW (kg) at 120 kVp, and the fixed-dose groups. Conclusions: In abdominal multiphasic contrast-enhanced CT, the TBW-based protocol of 450 mgI/kg at 100 kVp is recommended for assessing vasculature, and the TBW-based protocol of 500 mgI/kg at 120 kVp is recommended for parenchymal and tumor visualization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.